Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

BACKGROUND: The current use of targeted therapy plus neoadjuvant chemotherapy for inflammatory breast cancer (IBC) is based on data extrapolated from studies in non-IBC. We conducted a systematic review to determine whether neoadjuvant chemotherapy plus targeted therapy results in a higher pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051801/
https://www.ncbi.nlm.nih.gov/pubmed/33861773
http://dx.doi.org/10.1371/journal.pone.0250057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051801/
https://www.ncbi.nlm.nih.gov/pubmed/33861773
http://dx.doi.org/10.1371/journal.pone.0250057

Ejemplares similares